Aethlon Selling And Marketing Expenses from 2010 to 2024
| AEMD Stock | USD 0.61 0.02 3.39% |
Selling And Marketing Expenses | First Reported 2010-12-31 | Previous Quarter 7.4 B | Current Value 7.8 B | Quarterly Volatility 2.7 B |
Check Aethlon Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aethlon Medical's main balance sheet or income statement drivers, such as Interest Expense of 158.4 M, Other Operating Expenses of 13.3 M or Total Operating Expenses of 12.9 M, as well as many indicators such as Price To Sales Ratio of 14.85, Dividend Yield of 0.0 or PTB Ratio of 0.79. Aethlon financial statements analysis is a perfect complement when working with Aethlon Medical Valuation or Volatility modules.
Aethlon | Selling And Marketing Expenses |
Latest Aethlon Medical's Selling And Marketing Expenses Growth Pattern
Below is the plot of the Selling And Marketing Expenses of Aethlon Medical over the last few years. It is Aethlon Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aethlon Medical's overall financial position and show how it may be relating to other accounts over time.
| Selling And Marketing Expenses | 10 Years Trend |
|
Selling And Marketing Expenses |
| Timeline |
Aethlon Selling And Marketing Expenses Regression Statistics
| Arithmetic Mean | 1,017,269,634 | |
| Geometric Mean | 9,560,375 | |
| Coefficient Of Variation | 263.05 | |
| Mean Deviation | 1,756,959,691 | |
| Median | 3,646,941 | |
| Standard Deviation | 2,675,883,282 | |
| Sample Variance | 7160351.3T | |
| Range | 7.8B | |
| R-Value | 0.59 | |
| Mean Square Error | 5016058.4T | |
| R-Squared | 0.35 | |
| Significance | 0.02 | |
| Slope | 353,735,977 | |
| Total Sum of Squares | 100244918.7T |
Aethlon Selling And Marketing Expenses History
About Aethlon Medical Financial Statements
Aethlon Medical stakeholders use historical fundamental indicators, such as Aethlon Medical's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Aethlon Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aethlon Medical's assets and liabilities are reflected in the revenues and expenses on Aethlon Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aethlon Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 7.4 B | 7.8 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:Check out the analysis of Aethlon Medical Correlation against competitors. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.